NASDAQ:JNCE - Jounce Therapeutics Insider Trading Activity

-0.05 (-1.16 %)
(As of 07/18/2019 04:42 AM ET)
Today's Range
Now: $4.26
50-Day Range
MA: $4.57
52-Week Range
Now: $4.26
Volume43,000 shs
Average Volume183,517 shs
Market Capitalization$140.46 million
P/E RatioN/A
Dividend YieldN/A

Insider Trades

Jounce Therapeutics (NASDAQ:JNCE) Insider Buying and Selling Activity

Insider Ownership Percentage: 44.41%

Jounce Therapeutics (NASDAQ JNCE) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/15/2018Hugh M ColeInsiderBuy1,900$7.84$14,896.001,900View SEC Filing  
3/15/2018Barbara Gayle DuncanDirectorSell2,000$28.11$56,220.002,000View SEC Filing  
3/8/2018Elizabeth TrehuInsiderSell4,545$25.06$113,897.704,545View SEC Filing  
3/8/2018Kimberlee C DrapkinCFOSell5,267$25.01$131,727.675,267View SEC Filing  
3/8/2018Richard /Ca/ MurrayCEOSell16,334$25.10$409,983.4016,334View SEC Filing  
3/5/2018Elizabeth TrehuInsiderSell4,545$21.50$97,717.504,545View SEC Filing  
3/5/2018Kimberlee C DrapkinCFOSell5,267$21.42$112,819.142,775View SEC Filing  
3/5/2018Richard /Ca/ MurrayCEOSell16,334$21.43$350,037.6216,334View SEC Filing  
1/26/2018Barbara Gayle DuncanDirectorSell4,000$25.00$100,000.004,000View SEC Filing  
2/1/2017Celgene Switzerland LlcMajor ShareholderBuy625,000$16.00$10,000,000.00View SEC Filing  
2/1/2017John Duncan HiggonsDirectorBuy6,700$16.00$107,200.0027,025View SEC Filing  
(Data available from 1/1/2013 forward)
This page was last updated on 7/18/2019 by Staff

Featured Article: Conference Calls

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel